Summary:
Medigate founders launch ACT, a new cybersecurity startup with $20M Seed funding
ACT focuses on cloud security, offering actionable solutions beyond visibility
Team includes ex-Claroty executives and seasoned cybersecurity experts
Medigate, their previous venture, was acquired after raising only $50M
Claroty, another venture by the founders, was once valued at $3.5B
Jonathan Langer and Itay Kirshenbaum, the brains behind Medigate's $400M exit, are back in the game with a new cybersecurity venture, ACT. Joined by Stephen Goldberg, a former senior executive at Claroty, and Ilai Fallach, a seasoned cybersecurity executive, the team is set to redefine cloud security.
ACT has already secured $20 million in Seed funding from heavyweight investors Team8 and Bessemer Venture Partners. The startup is currently operating in stealth mode, focusing on providing more than just visibility and vulnerability disclosure. Their mission? To empower security teams with the tools to take concrete, effective action against cloud risks.
The Vision Behind ACT
Led by Langer as COO, Goldberg as Chief Product Officer, Kirshenbaum as CTO, and Fallach, ACT aims to bridge the gap in cloud security. The team's expertise, honed at Claroty and other cybersecurity giants, positions them uniquely to tackle the evolving threats in cloud environments.
A Look Back at Medigate
Before their latest venture, Langer and Kirshenbaum co-founded Medigate in 2017, a cybersecurity platform dedicated to protecting medical devices (IoMT). With just $50 million in funding, Medigate addressed a critical gap in healthcare security, safeguarding devices like CT scanners and infusion pumps from cyber threats. Their success culminated in a lucrative acquisition, setting the stage for their next big move.
Claroty's Market Position
Claroty, known for securing essential facilities and critical infrastructure, was once speculated to be eyeing an IPO at a $3.5 billion valuation. With annual revenues around $400 million, the company's growth trajectory underscores the potential of ACT, given its founders' proven track record.
Related Articles:
Comments